Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05801354 |
Other study ID # |
UHSUniversity |
Secondary ID |
|
Status |
Completed |
Phase |
Phase 1/Phase 2
|
First received |
|
Last updated |
|
Start date |
October 20, 2022 |
Est. completion date |
March 2, 2023 |
Study information
Verified date |
March 2023 |
Source |
University of Health Sciences Lahore |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The purpose of this randomized controlled clinical trial is to use Turmeric gel as non-vital
Pulpotomy medicament compared to Formocresol in primary teeth by evaluating its antibacterial
effect against Streptococcus mutans and Lactobacillus acidophilus. It is hypothesized that
there is no difference in the antibacterial effect of Turmeric gel compared with Formocresol,
when used as non-vital Pulpotomy medicaments.
Description:
It is a multi-arm parallel Randomized Controlled Trial in which forty patients aged between 4
to 8 years, each containing at-least one non-vital primary molar, will be selected and
randomly divided into Group A (Formocresol) and Group B (Turmeric gel). Non-vital Pulpotomy
will be performed by removing the coronal necrotic pulp. Sterile paper point will be dipped
in the root canals and taken to the laboratory. Cotton pellets soaked in the respective
medicaments will be placed over the root canal orifices and filled temporarily. Patients will
be recalled after one week. Samples will be again taken, and tooth restored. Comparison
between bacterial count at baseline and after one week of treatment will be made and
expressed as Colony-Forming Units/ml (CFU/ml).